SpliSense
Biotechnology Research
Jerusalem, 9190401, Il
15 employees
ENLV
- Employees
- 15
- Contacts
- 3
- Emails
- 3
SpliSense Overview
- Headquarters
- Jerusalem, 9190401, Il
- Website
- www.splisense.com
- Industry
- Biotechnology Research
- Employees
- 15
- Founded
- 2017
- Stock Symbol
- ENLV
- Funding
- 28.5M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About SpliSense
SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.
SpliSense Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
SpliSense Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Lital Friedman | VP Clinical and Regulatory Affairs | Jerusalem District, Israel |
Email
|
| Asaf Cohen | SVP Cmc and Operations at Splisense | Israel |
Email
|
| Ilana Bearman | Executive Assistant @ Splisense | Israel |
View
|
| Ido Zairi | Managing Partner at Israel Biotech Fund | United States |
Email
|
Employees by Management Level
Individual contributor
2 profiles
VP / Head
1 profile
Associate / junior
1 profile
Compare Similar Companies to SpliSense
1E Therapeutics
Pharmaceutical Manufacturing
Enlivex Therapeutics (Nasdaq: ENLV)
Pharmaceutical Manufacturing
Scinai Immunotherapeutics Ltd.
Biotechnology Research
Eleven Therapeutics
Research
KAHR-Medical Ltd.
Biotechnology Research
CURESPONSE
Biotechnology
Cytora Stem
Pharmaceutical Manufacturing
NeoTX Therapeutics LTD
Biotechnology
Nectin Therapeutics
Biotechnology
BioNanoSim
Biotechnology Research